WA SB5513

Expands pharmacist prescribing authority beginning December 1, 2026 to include immunizations, opioid antagonists, epinephrine autoinjectors, antihistamines, tobacco cessation products, HIV prevention medications, tuberculin tests, hormonal contraception, and travel-related medications

Allows pharmacists to prescribe drugs and devices for conditions that do not require new diagnosis, are minor and self-limiting, or have CLIA-waived diagnostic tests to guide treatment

Adds diagnosing conditions and prescribing drugs/devices to the statutory definition of "practice of pharmacy" under RCW 18.64.011

Addresses healthcare provider shortages in rural and underserved communities by enabling pharmacists to practice at the full extent of their education and training

New prescribing authority provisions expire January 1, 2030, and the pharmacy quality assurance commission may adopt implementing rules